Rare diseases
Investigational molecules
Locations
Moreelsepark 1, 3511 EP Utrecht, The Netherlands
Research activity in advanced triple-negative breast cancer centers on refining treatment choice through biomarker assessment, including the BRCA1-like test and response-linked outcomes in measurable and non-measurable disease.
The focus includes aligning alkylating agents, platinum agents, and taxane-based therapy with molecular features of the tumor.
BOOG Study Center B.V. runs clinical trials in conditions such as Hormone receptor positive HER2 negative breast cancer, Breast cancer metastatic, PIK3CA-activated mutation, Breast cancer stage III, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
The NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
